These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15647289)

  • 21. The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors.
    Lin J; Lee D; Choi Y; Lee SY
    Sci Signal; 2015 Jun; 8(379):ra54. PubMed ID: 26038599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha.
    Chaisson ML; Branstetter DG; Derry JM; Armstrong AP; Tometsko ME; Takeda K; Akira S; Dougall WC
    J Biol Chem; 2004 Dec; 279(52):54841-8. PubMed ID: 15485831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation.
    Lee SE; Woo KM; Kim SY; Kim HM; Kwack K; Lee ZH; Kim HH
    Bone; 2002 Jan; 30(1):71-7. PubMed ID: 11792567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration.
    Kwak HB; Lee SW; Jin HM; Ha H; Lee SH; Takeshita S; Tanaka S; Kim HM; Kim HH; Lee ZH
    Blood; 2005 Apr; 105(7):2963-9. PubMed ID: 15585657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative regulation of RANKL-induced osteoclastic differentiation in RAW264.7 Cells by estrogen and phytoestrogens.
    García Palacios V; Robinson LJ; Borysenko CW; Lehmann T; Kalla SE; Blair HC
    J Biol Chem; 2005 Apr; 280(14):13720-7. PubMed ID: 15644335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6.
    Mizukami J; Takaesu G; Akatsuka H; Sakurai H; Ninomiya-Tsuji J; Matsumoto K; Sakurai N
    Mol Cell Biol; 2002 Feb; 22(4):992-1000. PubMed ID: 11809792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E2 strongly inhibits human osteoclast formation.
    Take I; Kobayashi Y; Yamamoto Y; Tsuboi H; Ochi T; Uematsu S; Okafuji N; Kurihara S; Udagawa N; Takahashi N
    Endocrinology; 2005 Dec; 146(12):5204-14. PubMed ID: 16150915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage.
    Khapli SM; Mangashetti LS; Yogesha SD; Wani MR
    J Immunol; 2003 Jul; 171(1):142-51. PubMed ID: 12816992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible involvement of protein kinases and Smad2 signaling pathways on osteoclast differentiation enhanced by activin A.
    Murase Y; Okahashi N; Koseki T; Itoh K; Udagawa N; Hashimoto O; Sugino H; Noguchi T; Nishihara T
    J Cell Physiol; 2001 Aug; 188(2):236-42. PubMed ID: 11424090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF.
    Zauli G; Rimondi E; Nicolin V; Melloni E; Celeghini C; Secchiero P
    Blood; 2004 Oct; 104(7):2044-50. PubMed ID: 15213096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro.
    Tomita M; Li X; Okada Y; Woodiel FN; Young RN; Pilbeam CC; Raisz LG
    Bone; 2002 Jan; 30(1):159-63. PubMed ID: 11792579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP‑PKA/PI3K‑Akt signaling pathway.
    Xu S; Zhou W; Ge J; Zhang Z
    Mol Med Rep; 2018 Mar; 17(3):4702-4712. PubMed ID: 29328471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of basic calcium phosphate crystal-stimulated matrix metalloproteinase-13 expression by osteoarthritic synovial fibroblasts: inhibition by prostaglandin E2.
    Molloy ES; Morgan MP; Doherty GA; McDonnell B; O'Byrne J; Fitzgerald DJ; McCarthy GM
    Ann Rheum Dis; 2008 Dec; 67(12):1773-9. PubMed ID: 18223264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages.
    Rahman MM; Kukita A; Kukita T; Shobuike T; Nakamura T; Kohashi O
    Blood; 2003 May; 101(9):3451-9. PubMed ID: 12511413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of mechanical strain on the function of Gap junctions in osteocytes are mediated through the prostaglandin EP2 receptor.
    Cherian PP; Cheng B; Gu S; Sprague E; Bonewald LF; Jiang JX
    J Biol Chem; 2003 Oct; 278(44):43146-56. PubMed ID: 12939279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin E2-stimulated prostanoid EP4 receptors induce prolonged de novo prostaglandin E2 synthesis through biphasic phosphorylation of extracellular signal-regulated kinases mediated by activation of protein kinase A in HCA-7 human colon cancer cells.
    Fujino H; Seira N; Kurata N; Araki Y; Nakamura H; Regan JW; Murayama T
    Eur J Pharmacol; 2015 Dec; 768():149-59. PubMed ID: 26518053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of transforming growth factor-activated kinase-1 on tumor necrosis factor-α actions in human adipose tissue-derived stromal cells.
    Lee SY; Lee JH; Shin KK; Kim DS; Kim YS; Bae YC; Jung JS
    Stem Cells Dev; 2015 Apr; 24(7):836-45. PubMed ID: 25350220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E2 directly inhibits bone-resorbing activity of isolated mature osteoclasts mainly through the EP4 receptor.
    Mano M; Arakawa T; Mano H; Nakagawa M; Kaneda T; Kaneko H; Yamada T; Miyata K; Kiyomura H; Kumegawa M; Hakeda Y
    Calcif Tissue Int; 2000 Jul; 67(1):85-92. PubMed ID: 10908419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PGE2 potentiates tonicity-induced COX-2 expression in renal medullary cells in a positive feedback loop involving EP2-cAMP-PKA signaling.
    Steinert D; Küper C; Bartels H; Beck FX; Neuhofer W
    Am J Physiol Cell Physiol; 2009 Jan; 296(1):C75-87. PubMed ID: 19005164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs.
    Suzawa T; Miyaura C; Inada M; Maruyama T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Suda T
    Endocrinology; 2000 Apr; 141(4):1554-9. PubMed ID: 10746663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.